Can-Fite BioPharma (CANF) Total Current Liabilities (2014 - 2026)
Can-Fite BioPharma's Total Current Liabilities was $2.23 million in Q2 2026, up 5.0% from $2.12 million a year earlier.
Powered by 
Analysis
Can-Fite BioPharma (CANF) Total Current Liabilities (2014 - 2026) Analysis & Trends
At the end of FY2025, Total Current Liabilities at Can-Fite BioPharma came in at $2.73 million, up 33.1% from FY2024.
- Total Current Liabilities shows a five-year compound annual growth rate of 16.6% (FY2020 to FY2025).
- In earlier years, Total Current Liabilities was $2.05 million in FY2024 (+1.6%), $2.02 million in FY2023 (-19.3%), $2.5 million in FY2022 (-8.4%) and $2.73 million in FY2021 (+115.1%).
- Quarterly Total Current Liabilities has moved between $1.99 million (Q2 2024) and $2.9 million (Q1 2022) over five years.
- The best year-over-year quarter for Total Current Liabilities over five years was Q4 2021 (growth of 115.1%); the worst was Q3 2023 (a decline of 21.0%).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Total Current Liabilities (Qtr) |
|---|---|---|---|---|---|
| 1 | Johnson & Johnson | 645.01 Bn | 563.54 Bn | 17.26 Bn | 54.90 Bn |
| 2 | AbbVie | 465.23 Bn | 438.39 Bn | 12.70 Bn | 41.64 Bn |
| 3 | Merck | 368.40 Bn | 322.83 Bn | 12.21 Bn | 27.73 Bn |
| 4 | Novartis Ag | 278.02 Bn | 233.89 Bn | 11.24 Bn | 31.75 Bn |
| 5 | Astrazeneca | 254.57 Bn | 228.13 Bn | 12.86 Bn | -31.55 Bn |
| 6 | Amgen | 229.02 Bn | 184.42 Bn | 7.24 Bn | 25.50 Bn |
| 7 | Gilead Sciences | 187.74 Bn | 161.85 Bn | 6.22 Bn | 11.02 Bn |
| 8 | Pfizer | 163.75 Bn | 110.70 Bn | 10.94 Bn | 32.65 Bn |
| 9 | Vertex Pharmaceuticals | 133.45 Bn | 105.45 Bn | 2.84 Bn | 3.94 Bn |
| 10 | Can-Fite BioPharma | 1.82 Mn | -17.88 Mn | - | 2.23 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 2.23 Mn |
| Dec 31, 2025 | 2.73 Mn |
| Jun 30, 2025 | 2.12 Mn |
| Dec 31, 2024 | 2.05 Mn |
| Jun 30, 2024 | 1.99 Mn |
| Dec 31, 2023 | 2.02 Mn |
| Sep 30, 2023 | 2.21 Mn |
| Jun 30, 2023 | 2.23 Mn |
| Mar 31, 2023 | 2.89 Mn |
| Dec 31, 2022 | 2.50 Mn |
| Sep 30, 2022 | 2.80 Mn |
| Jun 30, 2022 | 2.15 Mn |
| Mar 31, 2022 | 2.90 Mn |
| Dec 31, 2021 | 2.73 Mn |
| Sep 30, 2021 | 2.15 Mn |
| Jun 30, 2021 | 2.36 Mn |
| Mar 31, 2021 | 2.06 Mn |
| Dec 31, 2020 | 1.27 Mn |
| Sep 30, 2020 | 1.82 Mn |
| Jun 30, 2020 | 1.50 Mn |
API Access
Can-Fite BioPharma Total Current Liabilities API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=total-current-liabilities&ticker=CANF&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "total-current-liabilities", "ticker": "CANF", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=total-current-liabilities&ticker=CANF&period=max&api_key=YOUR_API_KEY");
const data = await res.json();